Paraneoplastic Cushing's syndrome in prostate cancer: A difficult management problem

BJU International

Volumn 101, Issue 4, 2008, Pages 424-427

  Nimalasena, Samantha ^a   Freeman, Alex ^a   Harland, Stephen ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cushing's syndrome; Paraneoplastic; Prostate cancer

Indexed keywords

ABIRATERONE; AMINOGLUTETHIMIDE; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; CORTICOTROPIN; KETOCONAZOLE; METYRAPONE; MITOTANE; OCTREOTIDE; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG;

ADRENALECTOMY; CANCER CHEMOTHERAPY; CANCER GROWTH; CASTRATION; CLINICAL FEATURE; CUSHING SYNDROME; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG DETERMINATION; DRUG TOLERABILITY; HUMAN; MOLECULAR CLONING; MORBIDITY; MORTALITY; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SHORT SURVEY; SMALL CELL CARCINOMA; TREATMENT RESPONSE;

ADRENALECTOMY; CARCINOMA, SMALL CELL; CUSHING SYNDROME; HUMANS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PROGNOSIS; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 38549136410     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07294.x     Document Type: Short Survey

References (21)

1. Vuitch MF, Mendelsohn G. Relationship of ectopic ACTH production to tumour differentiation: a morphologic and immunohistochemical study of prostatic carcinoma with Cushing's Syndrome. Cancer 1981 47 : 296 9
2. Haukaas SA, Halvorsen OJ, Nygaard SJ, Paus E. Cushing's syndrome in prostate cancer. An aggressive course of prostatic malignancy. Urol Int 1999 63 : 296 9
3. Di Sant' Agnese PA. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic and therapeutic implications Cancer 1992 70 : 254 68
4. Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NG. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 1987 59 : 1803 9
5. Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma. Cancer 1997 79 : 1729 36
6. Schron DS, Gipson T, Mendelsohn G. The histogenesis of small cell carcinoma of the prostate: An immunohistochemical study. Cancer 1984 53 : 2478 80
7. Helpap B, Kollermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch 1999 434 : 385 91
8. Meador CK, Liddle GW, Island DP et al. Cushing's syndrome in patients with tumours arising from 'nonendocrine' tissue. J Clin Endocrinol Metab 1962 22 : 693 703
9. Rickman T, Garmany R, Doherty T, Benson D, Okusa MD. Hypokalaemia, metabolic alkalosis and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma. Am J Kid Dis 2001 37 : 838 46
10. Torpy DJ, Mullen N, Ilias I, Nieman LK. Association of hypertension and hypokalaemia with Cushing's syndrome caused by ectopic ACTH secretion. Ann NY Acad Sci 2002 970 : 134 44
11. Teves DA. Clinical approach of Cushing's Syndrome resulting from ACTH producing metastatic neuroendocrine tumour. Endocrinologist 2005 516 : 401 4
12. Oliver RL, Davis JR, White A. Characterisation of ACTH related peptides in ectopic Cushing's syndrome. Pituitary 2003 6 : 119 26
13. De Herder WW, Lamberts SW. Is there a role for somatostatin and its analogues in Cushing's syndrome? Metabolism 1996 45 (Suppl. 1 83 5
14. Isidori AM, Kaltsas GA, Pozza C et al. The ectopic adrenocorticotrophin syndrome: clinical features, diagnosis and long term follow-up. J Clin Endocrinol Metab 2006 91 : 371 7
15. Niemann LK. Medical therapy of Cushing's disease. Pituitary 2002 5 : 77 82
16. Winquist EW, Laskey J, Crump M, Khamsi F, Shepherd FA. Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotrophin production. J Clin Oncol 1995 13 : 157 64
17. Attard G, Yap TA, Reid AH et al. Phase I study of continuous oral dosing of an irreversibleCYP17 inhibitor, abiraterone (A), in castration refractoryprostate cancer (CRPC) patients (p) incorporating theevaluation of androgens and steroid metabolites in plasmaand tumor. ASCO Annual Proceedings Part I. J Clin Onc 2007 25 (18S 5063
18. Dimopoulos MA, Fernandez JF, Samaan NA, Holoye PY, Vassilopoulou-Sellin R. Paraneoplastic Cushing's syndrome, an adverse prognostic factor in patients who die early with small cell lung cancer. Cancer 1992 69 : 66 71
19. Delisle L, Boyer MJ, Warr D et al. Ectopic corticotrophin syndrome and small cell carcinoma of the lung. Clinical features, outcome and complications. Arch Intern Med 1993 153 : 746 52
20. Shepherd FA, Laskey J, Evans WK, Goss PE, Johansen E, Khamsi F. Cushing's syndrome associated with ectopic corticotrophin production and small cell lung cancer. J Clin Oncol 1992 10 : 21 7
21. Collichio FA, Woolf PD, Brower M. Management of patients with small cell carcinoma and the syndrome of ectopic corticotropin secretion. Cancer 1994 73 : 1361 7